Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Mediators of Inflammation|July 12, 2013
Visfatin/Nampt: an adipokine with cardiovascular impactTania Romacho, Carlos F Sánchez-Ferrer, Concepción PeiróJournal of Pediatric Surgery|November 21, 2012
Characterization of endothelium-dependent relaxations in the mesenteric vasculature: a comparative study with potential pathophysiological relevanceFernando Rivilla, Susana Vallejo, Concepción Peiró, et al.Frontiers in Pharmacology|August 12, 2011
Visfatin/PBEF/Nampt: A New Cardiovascular Target?Concepción Peiró, Tania Romacho, Raffaele Carraro, et al.Frontiers in Pharmacology|June 30, 2017
IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes MellitusConcepción Peiró, Óscar Lorenzo, Raffaele Carraro, et al.Frontiers in Pharmacology|August 28, 2020
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.Cardiovascular Diabetology|December 19, 2014
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic ratsSusana Vallejo, Erika Palacios, Tania Romacho, et al.Plos One|October 17, 2013
Visfatin as a novel mediator released by inflamed human endothelial cellsTania Romacho, Laura A Villalobos, Elena Cercas, et al.Cardiovascular Diabetology|February 20, 2024
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitusInés Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, et al.Frontiers in Physiology|July 12, 2012
Mechanisms involved in the aging-induced vascular dysfunctionMariam El Assar, Javier Angulo, Susana Vallejo, et al.Pageof 5